[Apropos of various vascular and respiratory manifestations with the use of adrenolytic substances during hyperbaric oxygenation in rats].
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D004877:Ergoloid Mesylates / Q000494:pharmacology; D006931:Hyperbaric Oxygenation; D007031:Hypothalamus / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008168:Lung / Q000187:drug effects; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D009929:Organ Size; D010100:Oxygen / Q000633:toxicity*; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects*; D012131:Respiratory Insufficiency / Q000139:chemically induced; D013565:Sympatholytics / Q000494:pharmacology*
D013565:Sympatholytics; D004877:Ergoloid Mesylates; D012110:Reserpine; D007545:Isoproterenol; D010100:Oxygen; D002746:Chlorpromazine; D009638:Norepinephrine; D010646:Phentolamine
A propos de quelques manifestations vasculaires et respiratoires avec l'emploi de substances adrénolytiques au cours de l'oxygénation hyperbarique chez le rat.